Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedJul 14, 2026
DataAggregated Company Financials
Companies13
- 7D2.9%
- 3M-15.8%
- 1Y-17.2%
- YTD-21.2%
Over the last 7 days, the Life Sciences industry has risen 4.0%, driven by gains from Shin Nippon Biomedical Laboratories of 7.3%. In the same time, Chiome Bioscience was down 7.6%. However, the industry is down 18% over the past year. Earnings are forecast to grow by 5.4% annually.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 14 Jul 2026 | JP¥114.9b | JP¥62.8b | JP¥631.5m | 24.1x | 182x | 1.8x |
| Thu, 11 Jun 2026 | JP¥104.8b | JP¥62.9b | JP¥618.3m | 22.4x | 169.5x | 1.7x |
| Sat, 09 May 2026 | JP¥140.3b | JP¥63.3b | -JP¥864,496,000.00 | 23.1x | -162.2x | 2.2x |
| Mon, 06 Apr 2026 | JP¥139.2b | JP¥63.3b | -JP¥864,496,000.00 | 20.7x | -161x | 2.2x |
| Wed, 04 Mar 2026 | JP¥148.4b | JP¥63.2b | -JP¥944,048,000.00 | 23x | -157.2x | 2.3x |
| Fri, 30 Jan 2026 | JP¥152.0b | JP¥66.9b | JP¥72.2m | 23.8x | 2105.2x | 2.3x |
| Sun, 28 Dec 2025 | JP¥151.2b | JP¥66.9b | JP¥72.2m | 21.3x | 2094.5x | 2.3x |
| Tue, 25 Nov 2025 | JP¥149.1b | JP¥67.3b | JP¥574.9m | 18x | 259.4x | 2.2x |
| Thu, 23 Oct 2025 | JP¥141.0b | JP¥66.5b | JP¥1.5b | 16.4x | 96.6x | 2.1x |
| Sat, 20 Sep 2025 | JP¥147.3b | JP¥66.5b | JP¥1.5b | 16.5x | 101x | 2.2x |
| Mon, 18 Aug 2025 | JP¥144.9b | JP¥66.5b | JP¥1.5b | 17.1x | 99.3x | 2.2x |
| Wed, 16 Jul 2025 | JP¥138.0b | JP¥66.0b | JP¥1.1b | 16x | 122.2x | 2.1x |
| Fri, 13 Jun 2025 | JP¥141.6b | JP¥66.0b | JP¥1.1b | 17.1x | 125x | 2.1x |
| Sun, 11 May 2025 | JP¥135.5b | JP¥65.9b | JP¥1.5b | 14.7x | 89.2x | 2.1x |
| Tue, 08 Apr 2025 | JP¥125.3b | JP¥64.8b | JP¥928.0m | 11.8x | 135x | 1.9x |
| Thu, 06 Mar 2025 | JP¥156.3b | JP¥65.1b | JP¥1.1b | 15.3x | 140x | 2.4x |
| Sat, 01 Feb 2025 | JP¥167.1b | JP¥62.0b | JP¥440.7m | 18.2x | 379.2x | 2.7x |
| Mon, 30 Dec 2024 | JP¥165.2b | JP¥62.0b | JP¥440.7m | 18.1x | 374.9x | 2.7x |
| Wed, 27 Nov 2024 | JP¥170.9b | JP¥62.0b | JP¥825.9m | 16.6x | 206.9x | 2.8x |
| Fri, 25 Oct 2024 | JP¥149.2b | JP¥61.5b | JP¥1.8b | 20.7x | 81x | 2.4x |
| Sun, 22 Sep 2024 | JP¥157.3b | JP¥61.5b | JP¥1.8b | 18.3x | 85.5x | 2.6x |
| Tue, 20 Aug 2024 | JP¥158.8b | JP¥61.7b | JP¥2.4b | 19.2x | 65.1x | 2.6x |
| Thu, 18 Jul 2024 | JP¥170.7b | JP¥61.8b | JP¥3.2b | 26.8x | 52.8x | 2.8x |
| Sat, 15 Jun 2024 | JP¥163.9b | JP¥61.8b | JP¥3.3b | 26.2x | 50.1x | 2.7x |
| Mon, 13 May 2024 | JP¥171.9b | JP¥62.0b | JP¥3.3b | 14.2x | 51.8x | 2.8x |
| Wed, 10 Apr 2024 | JP¥183.4b | JP¥62.3b | JP¥3.3b | 14.2x | 55.7x | 2.9x |
| Fri, 08 Mar 2024 | JP¥239.7b | JP¥155.3b | JP¥8.7b | 14x | 27.6x | 1.5x |
| Sun, 04 Feb 2024 | JP¥227.0b | JP¥155.5b | JP¥6.7b | 15.4x | 34x | 1.5x |
| Tue, 02 Jan 2024 | JP¥224.9b | JP¥167.1b | JP¥8.5b | 15x | 26.5x | 1.3x |
| Thu, 30 Nov 2023 | JP¥235.0b | JP¥167.4b | JP¥8.7b | 14.8x | 27.1x | 1.4x |
| Sat, 28 Oct 2023 | JP¥226.1b | JP¥179.3b | JP¥12.8b | 14.2x | 17.7x | 1.3x |
| Mon, 25 Sep 2023 | JP¥250.8b | JP¥179.3b | JP¥12.8b | 15.4x | 19.6x | 1.4x |
| Wed, 23 Aug 2023 | JP¥258.3b | JP¥179.3b | JP¥12.8b | 16.2x | 20.2x | 1.4x |
| Fri, 21 Jul 2023 | JP¥273.1b | JP¥178.7b | JP¥15.7b | 16.5x | 17.4x | 1.5x |
Price to Earnings Ratio
17.4x
Current Industry PE
- Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 181x which is higher than its 3-year average PE of 177x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 66% per year over the last three years,
- Revenues have also declined 29% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -2.63% | |
| Healthcare | -3.01% | |
| Life Sciences | 2.85% | |
| Clinical Research and Equipment | 2.85% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.30k | 7.8% +JP¥3.9b | -4.7% | PE11.9x | |
| 7707 Precision System Science | JP¥206.00 | 6.2% +JP¥329.5m | 5.6% | PE42.2x | |
| 4880 CellSource | JP¥345.00 | 4.9% +JP¥317.6m | -48.9% | PE97.8x | |
| 7079 WDB coco | JP¥2.60k | 1.3% +JP¥79.4m | -10.9% | PE9.2x | |
| 4892 Cyfuse Biomedical K.K | JP¥550.00 | 0.4% +JP¥19.9m | -19.2% | PS23.4x |